Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of the Safety and Efficacy Between Paclitaxel-Eluting Coronary Balloon Dilation Catheter (DIOR) and Paclitaxel-Eluting Balloon (Bingo) in Coronary Bifurcation Lesions: A Prospective, Multicenter, Randomized, Controlled Trial (BEYOND II)

NCT03820622 is registered in ClinicalTrials.gov with CCRF Inc., Beijing, China as lead sponsor.

NCT NCT03820622
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03820622 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of the Safety and Efficacy Between Paclitaxel-Eluting Coronary Balloon Dilation Catheter (DIOR) and Paclitaxel-Eluting Balloon (Bingo) in Coronary Bifurcation Lesions: A Prospective, Multicenter, Randomized, Controlled Trial (BEYOND II)
Lead sponsor
CCRF Inc., Beijing, China
Phase
Not applicable
Overall status
Unknown status
Start date
March 31, 2019
Completion date
October 31, 2022
Enrollment
220 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

percutaneous coronary intervention